Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 35

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 35
---
, to the effect that, as of that date and based on and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations on the review undertaken described in such opinion, the Business Combination is fair, from a financial point of view, to the BLAC stockholders. On September 17, 2024, Choloc rendered its fairness opinion to the BLAC M&A Committee. A copy of the fairness opinion delivered by Choloc to the BLAC M&A Committee is included as (and is attached to and incorporated as) Annex I to this proxy statement/prospectus. For additional information, see “ The Business Combination — The BLAC M&A Committee’s Reasons for the Approval of the Business Combination — Fairness Opinion of Choloc Asset Investment Advisory Co., Ltd.” In addition, the officers and directors of BLAC have substantial experience in evaluating the operating and financial merits of companies from a wide range of industries including healthcare and concluded that their experience and background, together with the experience of their representatives, also enabled them to make the necessary analyses and determinations regarding the Business Combination, prior to obtaining, but ultimately subject to the receipt of, a fairness opinion. See “ The Business Combination — The BLAC M&A Committee’s Reasons for the Approval of the Business Combination — Comparable Company Analysis” and “The Business Combination — The BLAC M&A Committee’s Reasons for the Approval of the Business Combination — Fair Market Value”for discussions on the BLAC M&A Committee’s analysis of comparable companies of OSR Holdings and the fair market value reports on OSR Holdings’ subsidiaries. Q: What will OSR Holdings’ equity holders receive in return for the Business Combination with BLAC? A:On the Closing Date (as defined in the Business Combination Agreement), BLAC shall issue to the Participating Company Stockholders up to an aggregate of 24,461,214shares of BLAC common stock, par value $0.0001 per share (“BLAC Common Stock”), and the Participating Company Stockholders will transfer their respective shares of OSR Holdings’ Series A common stock, with a par value of KRW 5,000 per share (“OSR Holdings Common Stock”), to BLAC (the “Share Exchange”). The Per Share Consideration that the Participating Company Stockholders will receive at Closing (as defined in the Business Combination Agreement) equates to $129.62. It is a condition to closing of the Share Exchange that BLAC will acquire from the Participating Company Stockholders at least